Observational study on amyotrophic lateral sclerosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather extensive biological and clinical data on amyotrophic lateral sclerosis (ALS) and related motor neuron diseases. Participants, including adults diagnosed with ALS, those with known mutations associated with ALS, and healthy volunteers, will contribute both prospective and retrospective data remotely. The findings from this study are intended to enhance drug discovery, identify biomarkers, and validate outcome measures for ALS. The study is sponsored by the ALS Therapy Development Institute.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Can communicate in written English
* Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation

Exclusion Criteria:

* Significant cognitive impairment that would prevent individual completion and understanding of the informed consent process.

Where it's running

• ALS Therapy Development Institute
  Watertown, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Fernando G Vieira, M.D. — ALS Therapy Development Institute
• Study coordinator: Alan S Premasiri, M.S.
• Email: apremasiri@als.net
• Phone: 617-441-7200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registering medical data and care outcomes for ALS, SMA, and other motor disorders

  This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.

  Recruiting Ambulanzpartner Soziotechnologie APST GmbH · Berlin, State of Berlin · NCT07900672

• Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders

  We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven, Vlaams-Brabant · NCT07509125

• How physical functioning relates to quality of life for people with ALS at TidalHealth

  This study will see if physical functioning scores relate to quality of life for adults with ALS who receive care at TidalHealth Peninsula Regional.

  Recruiting TidalHealth · Salisbury, Maryland · NCT07491484

• Tongue-strengthening exercises for people with ALS

  This program will test whether daily tongue-strengthening exercises can help people with ALS maintain or improve speech and swallowing.

  Recruiting Nova Southeastern University · Davie, Florida · NCT07295990

• Acamprosate for ALS with C9orf72 mutation

  This study tests whether acamprosate can be safely used to see if it helps people with ALS who carry a C9orf72 mutation.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07204977

• Understanding the variability in ALS through biomarkers

  This study is trying to see how different biological markers can help us understand the varying symptoms of ALS in patients and group them based on their unique characteristics.

  Recruiting at 3 sites Istituto Auxologico Italiano · Milan, MI and 2 other locations · NCT06318598

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.